000 01467 a2200409 4500
005 20250514163110.0
264 0 _c20031211
008 200312s 0 0 eng d
022 _a1524-4571
024 7 _a10.1161/01.RES.0000105871.05032.53
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFeil, Robert
245 0 0 _aAlternative splicing of cGMP-dependent protein kinase I and nitrate tolerance.
_h[electronic resource]
260 _bCirculation research
_cNov 2003
300 _ae143 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAlternative Splicing
_xdrug effects
650 0 4 _aAngiotensin II
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBasilar Artery
_xenzymology
650 0 4 _aCyclic GMP
_xpharmacology
650 0 4 _aCyclic GMP-Dependent Protein Kinase Type I
650 0 4 _aCyclic GMP-Dependent Protein Kinases
_xgenetics
650 0 4 _aDNA, Complementary
650 0 4 _aDrug Tolerance
_xgenetics
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aIntrons
650 0 4 _aIsoenzymes
_xgenetics
650 0 4 _aMuscle, Smooth, Vascular
_xdrug effects
650 0 4 _aNitrates
_xpharmacology
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aRats
650 0 4 _aReproducibility of Results
700 1 _aHofmann, Franz
773 0 _tCirculation research
_gvol. 93
_gno. 11
_gp. e143
856 4 0 _uhttps://doi.org/10.1161/01.RES.0000105871.05032.53
_zAvailable from publisher's website
999 _c14379781
_d14379781